Number of outstanding shares in Elekta AB (publ)

Thu Jan 31, 2013 12:10pm EST

* Reuters is not responsible for the content in this press release.

STOCKHOLM, Sweden--(Business Wire)--
Regulatory News: 

During January, 16 476 new B shares were issued in Elekta through conversion to
shares within the framework of the 2012/17 convertible bond. 

The total number of shares in Elekta as of January 31, 2013, amounts to
382,823,805 divided between 14,250,000 A shares and 368,573,805 B shares. 

One A share entitles the holder to ten votes and one B share to one vote. 


The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 18.00 CET on January 31, 2013. 

About Elekta Elekta is a human care company pioneering significant innovations
and clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning systems
for radiation therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care. Stretching the
boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives. 

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: 

This information was brought to you by Cision

For further information, please contact:
Johan Andersson Melbi, Director Investor Relations
Elekta AB. Tel: +46 702 100 451

Copyright Business Wire 2013